PureTech Health PLC (PRTC) Stock Analysis

PureTech Health PLC (PRTC) is a publicly traded company in the HEALTHCARE sector. It trades at $17.42. This page summarizes the public market data, fundamentals, and frequently asked questions for PRTC, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $17.42

Market Sentiment

PureTech Health PLC currently has a Bullish sentiment score of 0.15.

About PureTech Health PLC

PureTech Health PLC is a Boston-based clinical-stage biotherapeutics company dedicated to developing innovative therapies for complex diseases, including inflammatory, fibrotic, immune-related conditions, and various cancers affecting lymphatic and gastrointestinal systems. The company boasts a strong pipeline of drug candidates and leverages its unique research platform alongside strategic collaborations to address significant unmet medical needs. With its expertise in neurological and neuro...

GNG Research Analysis

GNG Research scores PureTech Health PLC (PRTC) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for PRTC.

Frequently Asked Questions

Does PRTC pay dividends?

PureTech Health PLC (PRTC) does not currently pay a regular dividend.